Thrombocytopenia remains a common and challenging condition in the management of hematologic disorders and complications associated with chronic liver disease. It not only significantly increases the risk of bleeding but may also delay essential surgical or invasive procedures, thereby adversely affecting patient outcomes.Avatrombopag, a next-generation oral thrombopoietin receptor agonist...